GoodRx Holdings, Inc. — Director's Dealing 2021

Oct 13, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GoodRx Holdings, Inc. (GDRX)
CIK: 0001809519
Period of Report: 2021-10-07

Reporting Person: NAGJI BANSI (President, Healthcare)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-10-07	Class A Common Stock	M	3600	$6.84	Acquired	32766	Direct
2021-10-07	Class A Common Stock	S	3600	$45.0519	Disposed	29166	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-07	Stock Option (Right to Buy)	$6.84	M	3600	Disposed	2030-06-15	Class A Common Stock (3600)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2: This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.18. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The option vested and became exercisable as to 25,000 shares on the closing date of the Issuer's initial public offering of securities, and vested or will vest as to 1/48th of the original 400,000 shares monthly thereafter until fully vested on June 10, 2024.

F4: The Reporting Person's prior Form 4 filed on September 16, 2021 incorrectly stated that 309,564 shares underlying this option remained after the reported transactions and should have reported 309,584 shares underlying this option after the reported transactions.